Navigation Links
ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
Date:11/12/2008

of the results of any future testing. The FDA may view the data regarding the use of Cinryze for acute treatment of HAE we intend to submit as a supplemental BLA as insufficient or inconclusive, request additional data, delay any decision past the time frames anticipated by us, limit any approved indications, or deny the approval of Cinryze for acute treatment of HAE. These factors, and other factors, including, but not limited to those described in ViroPharma's annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission during 2008, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
2. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
3. ViroPharma Announces Discontinuation of HCV-796 Development
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. ViroPharma to Present at the Natixis Bleichroeder Conference
7. ViroPharma to Present at Three Upcoming Healthcare Conferences
8. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
9. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
10. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
11. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015  PD-Rx Pharmaceuticals, Inc., a publicly held ... partnered with Dobson Technologies, a fully-integrated outsourced IT ... product. PD-Rx is an Application Service ... States.  Using Dobson Technologies, IaaS solution will allow ... ensure regulatory compliance, and reduce operating expenses.  "The ...
(Date:7/28/2015)... At the 2015 ICX Association Excellence ... 15 winners in the categories of digital signage, ... vertical markets. ContextMedia:Health proudly took home the ... success with its first-to-market Patient Education Exam ... leading provider of digital solutions at point-of-care, ...
(Date:7/28/2015)... July 28, 2015 Research and Markets ... the "Global Hearing Aids Market 2015-2019" ... global hearing aids market to grow at a ... Factors such as changing demographics and ... growth. The market has witnessed immense technological advances. ...
Breaking Medicine Technology:PD-Rx Partners With Dobson Technologies 2ContextMedia:Health Receives Top Award at the ICX Association Excellence Awards 2Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2
... be tested in AMD patients, LOUISVILLE, Ky., ... company developing medicines for the treatment,of age-related macular ... candidate, POT-4, has shown early positive safety,results in ... inhibitor, which shuts,down the complement activation cascade that ...
... collaborates with Dikembe Mutombo Foundation to improve healthcare,system ... NEW YORK, Sept. 25 The Clinton Global,Initiative ... BDX ), a,leading global medical technology company, for ... enhance immune system monitoring and,healthcare worker safety at ...
Cached Medicine Technology:Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 3
(Date:7/29/2015)... MO (PRWEB) , ... July 29, 2015 , ... ... of a decision from the Judicial Panel on Multidistrict Litigation (JPML), according to ... birth defects research at their website, the Zofran Birth Defects Lawsuit Center. , ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... a global provider of life insurance, annuities, employee benefits and asset management, has ... inclusive sporting event taking place in Charlotte, North Carolina on October 2-4, ...
(Date:7/29/2015)... ... July 29, 2015 , ... Elizabeth ... in Sarasota to be chosen by the manufacturer to offer and perform ... injectable, non-invasive way to treat and eliminate double chin fat,” Dr. Callahan explained. ...
(Date:7/29/2015)... ... 2015 , ... Nature’s Artisan, a new holistic oral care company, has released ... was founded by Tina Yarandi, who came up with the idea for the product ... was amazed when she learned about the incredible dental benefits of xylitol, but was ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Every July, since ... with the disease only experience through movies and television. They go to summer camp. ... the right side of the heart as it pushes hard to get blood through ...
Breaking Medicine News(10 mins):Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3
... can deliver organized follow-up care for depression effectively and ... Group Health patients that the Journal of General ... After five months, compared to the half of ... half who had three online care management contacts with ...
... WEDNESDAY, March 16 (HealthDay News) -- Newly proposed national ... from power plants could prevent as many as 17,000 ... to the U.S. Environmental Protection Agency. The proposed ... a court deadline, could also prevent 120,000 cases of ...
... French . , Toronto (March 16, 2011) ... received $16 million in funding. The studies, co-funded by the ... Agency (CSA), were announced today at the University of Toronto ... Jane Aubin, Scientific Director of the Canadian Institutes of Health ...
... HealthDay Reporter , TUESDAY, March 15 (HealthDay ... chatting on cell phones while crossing the street, because ... age group than for college students. In laboratory ... aged 59 to 81 and 18 undergraduates aged 18 ...
... 2011 -- Children and adolescents growing up with inflammatory bowel ... study by researchers at McMaster University and the McMaster Children,s ... Pediatrics online, shows children and youth with the most ... 25 per cent lower than other children their age, and ...
... , TUESDAY, March 15 (HealthDay News) -- The cholera ... the 400,000 cases predicted by the United Nations, new study ... cases of the potentially deadly diarrheal disease -- an estimated ... to researchers at the University of California, San Francisco and ...
Cached Medicine News:Health News:Online messaging delivers follow-up care for depression 2Health News:EPA Proposes Tougher Air Pollution Rules for Power Plants 2Health News:Important funding for nanomedicine research to improve diagnosis and treatment 2Health News:Important funding for nanomedicine research to improve diagnosis and treatment 3Health News:Crossing Street While on Cell Phone Risky for Seniors 2Health News:Youth with IBD are less fit than their peers: McMaster study 2Health News:Haiti Cholera Epidemic Could Sicken 779,000 This Year 2
Nucleus Hydrodissection Cannula, 25 g. Angled with flattened tip. 7 mm angled shaft with flattened tip for insertion under the capsular flap. Overall length 19 mm. 5/box....
Posterior Capsule Polisher, 21 g. Roughened tip, top port. Overall length 23 mm. 5/box....
Irrigating Cystotome, Straight, 25 g. Overall length 15 mm. 5/box....
Irrigating Cystotome, formed, 25 g., 12 mm curved tip. Overall length 14 mm. 5/box....
Medicine Products: